Longitudinal multiplex cytokine analysis for patients (pts) with metastatic renal cell carcinoma (mRCC) treated with ipilimumab/nivolumab (I+N). This is an ASCO Meeting Abstract from the 2020 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results